Unlock all Features See Plans and Pricing

Serving leading biopharmaceutical companies globally:

McKinsey
Moodys
McKesson
AstraZeneca
Dow
Harvard Business School

Last Updated: September 26, 2022

Patent: 5,112,757


✉ Email this page to a colleague

« Back to Dashboard

▶ Start for $1
Remove trial restrictions


Summary for Patent: 5,112,757
Title: Method for obtaining human hepatocyte cultures
Abstract:A method for culturing human hepatocytes is disclosed. The method comprises associating a culture of human hepatocytes including a medium with cells of hepatic origin, these cells being different from the hepatocytes and being of the type insuring in vivo specific cellular interactions with the hepatocytes. The culture obtained maintains hepatocyte functions at a high level for an extended period of time.
Inventor(s): Guguen-Guillouzo; Christiane (Rennes, FR), Guillouzo; Andre (Rennes, FR), Bourel; Michel (Rennes, FR)
Assignee: Institut National de la Sante et de la Recherche (Paris, FR)
Application Number:07/034,983
Patent Claims:see list of patent claims

Details for Patent 5,112,757

Applicant Tradename Biologic Ingredient Dosage Form BLA Approval Date Patent No. Expiredate
Smith & Nephew, Inc. SANTYL collagenase Ointment 101995 06/04/1965 See Plans and Pricing 2009-05-12
>Applicant >Tradename >Biologic Ingredient >Dosage Form >BLA >Approval Date >Patent No. >Expiredate

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Colorcon
McKesson
McKinsey
Dow
Harvard Business School
AstraZeneca

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.